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Abstract
Background: Total knee arthroplasty (TKA) is an effective treatment for end-stage osteoarthritis. Patient reported-
outcome measures (PROMs) capture the patients’ perception of the success of an intervention. The minimal
important difference (MID) is an important characteristic of the PROM, which helps to interpret results. The aim of
this study was to identify the MID for the Forgotten Joint Score-12 (FJS-12) and Western Ontario and McMaster
Universities (WOMAC) osteoarthritis index.
Methods: Data were collected in a prospective cohort study. Patients were asked to complete the FJS-12, WOMAC
osteoarthritis index and transition items evaluating change over time to determine the MID. We employed an
anchor-based methodology relating score change to the response categories of the transition items using both
binary logistic regression and receiver operating characteristic (ROC) analysis.
Results: Data from 199 patients were analysed. Mean age was 72.3 years, 58% were women. Employing binary
logistic regression the MID for the FJS-12 was 10.8 points, for the WOMAC pain score 7.5 points and for the
WOMAC function score 7.2 points. ROC analyses found a MID of 13.0 points for the FJS-12, 12.5 points for WOMAC
pain and 14.7 points for WOMAC function.
Conclusion: We report MIDs for the FJS-12 and the WOMAC Pain and Function scales in a TKA patient cohort,
which can be used to interpret meaningful differences in score. In line with previous research, we found more
advanced statistical methods to result in smaller MID estimates for both scores.
Trial registration: Written consent for this study was obtained from all participants and ethical approval was
granted by the local ethics committee (Ethikkommission St. Gallen; EKSG 14/973; Registered 03 July 2014;
http://www.sg.ch/home/gesundheit/ethikkommission.html).
Keywords: Minimal important difference, Forgotten Joint Score-12, Western Ontario and McMaster universities
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Background
Total knee arthroplasty (TKA) is well established to im-
prove pain and function in patients suffering from end-
stage osteoarthritis of the knee [1]. Outcomes of surgery
can be assessed in various ways; by implant survival,
image-based assessment, clinical examination or patient-
reported outcome measures (PROMs). PROMs offer a
view of outcome from the patient perspective and are
now commonplace in both research and clinical practice.
Numerous PROMs have been shown to be valid and re-
liable for use in TKA typically evaluating pain, function,
or treatment satisfaction [2–10].
PROM outcomes are typically presented as score
points (usually via a 0–100 range), but this is somewhat
abstract and can be difficult to interpret. To judge the
effectiveness of an intervention and interpret the differ-
ence between randomised groups in a clinical trial, a
meaningful quanta of change on the score range must
be contextualised to determine whether a statistically
significant result is also clinically meaningful.
Determining minimal important differences (MIDs) of
a score can support the decision as to clinical relevance
of score differences. The MID has been defined as “the
smallest change in an outcome that a patient would
identify as important” [11]. A variety of methodological
approaches to determine the MID for a PROM exist.
The most informative are anchor-based methods that re-
late score differences to external criteria [12]. Frequently
this is done relying on transition items to assess the de-
gree to which an individual can perceive an improve-
ment or deterioration between two assessment time
points. The responses concerning the experienced
change are then related to differences in PROM scores
obtained at those two time points, thus “anchoring” the
PROM scores to the degree of change perceived by the
patient [13]. Previously mean score change related to the
magnitude of perceived change has been analyzed [11]
and receiver operator characteristics (ROC) method-
ology have been used to calculate MIDs. More recently
however Terluin et al. [14] described a logistic regression
modelling approach that is more accurate and less
dependent on the correlation between PROM score and
anchor responses.
The Western Ontario and McMaster Universities
index (WOMAC) has been used for decades as a meas-
ure of arthroplasty success [3]. It has various estimates
of MID, but none derived from a logistic regression
model. Various estimates have been proposed for
WOMAC MID. To determine the MID in patients with
OA of the knee undergoing TKA Escobar et al. [15] per-
formed a 1-year prospective multicentre study and re-
ported a MID of 22 points for WOMAC pain and 24
points for WOMAC function based on ROC analysis.
Terwee et al. 2010 evaluated various methods of
calculating MID for the WOMAC score and reported up
to 29.4 points for pain and 22.8 points for function sub-
scores using ROC analysis. Both of these estimates are
unexpectedly high as they exceed the standard deviation
of the baseline score.
Previously, Terwee et al. [16] calculated the MID for
WOMAC in an arthroplasty population of patients
undergoing primary and revision hip and knee surgery
and reported lower MIDs of 16.5 points for pain and 9.6
points for function (values rescaled to a 0–100 metric
for comparability). The Forgotten Joint Score-12 is a
more recent PROM, developed to evaluate joint aware-
ness [2]. This score is now well used in knee arthroplasty
cohorts and is thought to offer improved discrimination
of patients with high functional levels and little pain
[17–20]. To date there has only been a single anchor-
based estimate of MID reported for the FJS-12 that eval-
uated the change between pre-operative values and 1-
year outcomes [21]. Ingelsrud et al. [21] calculated a
MID of 14 points for change in the FJS-12 between pre-
op and 1 year following TKA for primary OA in a pro-
spective cohort study with patient data from one Danish
hospital using a regression modelling approach. Calcu-
lating the MID using a ROC methodology, they found a
MID of 17 points.
MIDs have been reported to be specific for patient
populations, which means that a single PROM can have
different MIDs in different patient groups [22]. Further
MID may change across different assessment time-
frames. By measuring the change between preoperative
status (very poor function) and 1-year post-arthroplasty
recovery (high level of function) a large difference in
outcome is evident, and the most robust estimates of the
minimal score change required to offer a detectably dif-
ferent outcome to the patient may not be apparent.
The aim of this study was to calculate MIDs after TKA
for the WOMAC osteoarthritis index and the FJS-12 using
the currently most accurate predictive modelling approach
and assessing change at differing post-operative time
points up to 2 years after surgery, to calculate the most ap-
propriate MID.
Methods
Study design, setting and participants
Between 2015 and 2018 we invited patients that had
undergone unilateral TKA at the Kantonsspital St. Gal-
len (Switzerland) and were included in the local joint
registry, to participate in this prospective study. Patients
were contacted via mail up to 24months after surgery
and were asked to complete the Forgotten Joint Score-
12 (FJS-12), the WOMAC Osteoarthritis Index, two
questionnaires assessing change in joint awareness re-
spectively pain and function, and a clinical data form. If
the completed questionnaire was not received within a
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two-week interval, patients received a telephone re-
minder and if necessary, a new questionnaire was sent
by mail. Patients were excluded from the study if they
had undergone any other intervention in the meantime
(any knee revision surgery or knee injection on the af-
fected side). Written consent was obtained from the par-
ticipants and ethical approval was granted by the local
ethics committee (EKSG 14/973).
Forgotten joint score (FJS-12)
The FJS-12 assesses joint awareness during activities of
daily living [23]. From 12 questions with five response
categories a total score is calculated ranging from 0 to
100 points. High values indicate a high degree of being
able to forget the joint in daily life (i.e. low joint aware-
ness). The FJS-12 has been validated in a number of
studies [2, 24–26] and has been shown to have notably
low ceiling effects and a wide measurement range [27],
excellent retest reliability [28, 29], and high responsive-
ness to change [17].
WOMAC osteoarthritis index
Bellamy and Buchnan [7] introduced the WOMAC
osteoarthritis (OA) index in 1988 as a self-reported out-
come measure in patients with lower limb OA. The ori-
ginal score with 5-point Likert response categories
consists of 24 questions covering three dimensions: pain
(five questions), stiffness (two questions) and function
(17 questions). Multiple studies tested the WOMAC
osteoarthritis index for validity, reliability, feasibility and
responsiveness to measure changes after different OA
interventions [3, 16]. The WOMAC osteoarthritis index
is scored from 0 to 100 points. In our study, a high score
is associated with less severe impairment for ease of in-
terpretation and comparison to the other scores.
Transition items for assessing change in outcome
To determine the MID with an anchor-based approach
we used transition items assessing the change in an out-
come parameter between the study time point and a pre-
vious reference time point.
For patients completing the questionnaires up to 1
year after surgery the transition items asked about
change in outcome parameters (joint awareness, pain,
and function) since their preoperative status. Patients
responding more than 1-year after surgery, were asked
to rate changes since the 1-year follow-up visit at the
hospital.
We used three transition items relating to change in
joint awareness, pain and function, with seven response
categories:
 How has your pain in the operated knee changed
since the pre-operative/1-year follow-up visit at the
hospital?
Much worse - Worse - A little worse - Neither better
nor worse - A little better - Better - Much better
 How have your difficulties with your operated knee
regarding daily activities changed since the pre-
operative/1-year follow-up visit at the hospital?
Much worse - Worse - A little worse - Neither better
nor worse - A little better - Better - Much better
 Compared to the pre-operative/1-year follow-up
visit at the hospital are you more or less aware of
your operated knee?
Much more - More - A little more - Neither more nor
less - A little less - Less - Much less
Statistical analyses
Patient data are described with means and standard de-
viations. FJS-12 and WOMAC osteoarthritis index
change by anchor response categories are displayed as
boxplots. The association between FJS-12 and WOMAC
osteoarthritis index change and responses to the transi-
tion items was assessed with the Spearman correlation.
Change in FJS-12 and WOMAC osteoarthritis index
between the assessment and the reference point (pre-
surgery and 1-year follow-up respectively) was calculated
as the difference between the score at the study time
point and the score at the reference time point (for
which FJS-12 and WOMAC data was available from the
local joint registry).
Estimation of MIDs were determined anchor-based by
relating change in PRO scores to the response categories
of the transition items. The primary analysis was by pre-
dictive modelling [14] using a binary logistic regression
model to predict the dichotomous criterion: improve-
ment (a little better – better – much better) versus no
improvement (neither better nor worse – a little worse –
worse – much worse) using the change in PRO score be-
tween the time points as continuous predictor. The
model did not account for repeated assessments in the
same patient. In such a model the MID equals the score
change that provides the same probability for belonging
to the improved or the not-improved group. Addition-
ally, we analysed a possible difference in MID for the
first and second year after surgery by adding a binary
timepoint variable (follow-up assessment before vs after
12 months post surgery) to the logistic regression model.
This model comprised the independent variables: change
in PRO score, timepoint, and their two-way interaction.
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As a secondary analysis we also determined MIDs
using ROC analysis that estimates the MID by relating
the score change (a metric variable), to the binary vari-
able (no improvement vs improvement) derived from
the transition item. The change score provides highest
sensitivity and specificity (i.e. the highest Youden’s J stat-
istic) for predicting improvement is selected as the MID.
Results
Of 309 patients that were eligible and were contacted for
participation in the study, a total of 199 patients (64.4%)
provided complete questionnaires for analysis. Mean pa-
tient age was 72.3 years (SD 9.9) and 116 (58.3%) were
female. A total of 104 prostheses were implanted to the
right knee (52.3%) and 95 to the left (47.7%) (Table 1).
In the first period (up to 12months, with pre-op score
as reference), 162 patients provided 162 change assess-
ments, i.e. no patient provided two change assessments.
In the second period, (after 12 months, with 12-month
score as reference), 37 patients provided 51 change as-
sessments, i.e. 14 patients provided two assessments.
This resulting in 213 individual study time points (with
corresponding reference time points) available for as-
sessment. Descriptive data for these time points is pre-
sented in Table 2.
An improvement of joint awareness was reported by
65.7% of patients, compared to 75.1% of patients
reporting less pain and 76.2% reporting better function.
Details are given in Table 3. Mean score change for the
FJS-12 and the WOMAC are shown for each response
category of the transition items in Fig. 1, 2 and 3.
For the FJS-12 the correlation between the transition
item and change between the study time point and the
reference time point was r = 0.59 (p < 0.001). For
WOMAC Pain this correlation was r = − 0.45 (p < 0.001)
and for WOMAC Function r = − 0.48 (p < 0.001). Binary
logistic modelling offered narrower minimal change esti-
mates than ROC methodology, Table 4.
Using regression modelling, the MID was 10.8 points
for the FJS-12 (constant = − 0.679, beta = 0.063). For the
WOMAC Pain scale (regression model: constant = −
0.514, beta = 0.069) the MID was 7.5 and for the
WOMAC Function scale (regression model: constant =
− 0.648, beta = 0.089) the MID was 7.2 points. Beta coef-
ficients were statistically significant (p < 0.001) in all
models.
In an additional analysis, we investigated a possible
change of size of MID over time, but did not find a dif-
ference comparing the first and second year post-surgery
for the FJS-12 (p = 0.983), WOMAC Pain (p = 0.171),
and WOMAC Function (p = 0.910).
Using ROC analysis, a MID of 13.0 points (sensitivity
0.84 and specificity 0.71) was determined for the FJS-12.
The AUC was 0.87 (95%CI 0.82–0.91), For the WOMAC
Pain scale the MID from the ROC analysis was 12.5
points (sensitivity 0.91, specificity 0.67) with an AUC of
0.83 (95%CI 0.75–0.90). For WOMAC Function the
MID was 14.7 points (sensitivity 0.85, specificity 0.76)
with an AUC of 0.87 (0.81–0.93).
Discussion
We have established a minimal important difference of
10.8 points for the FJS-12, 7.5 points for the WOMAC
Table 1 Sample characteristics
Age Mean (SD) 72.3 (9.9)
BMI Mean (SD) 30.5 (5.3)
Sex N (%) female 116 (58.3%)
male 83 (41.7%)
Side N (%) Left 95 (47.7%)
right 104 (52.3%)
Table 2 Descriptive statistics for FJS-12 and WOMAC osteoarthritis index across study time points






Reference time point: pre-surgerya 162 11.7 (11.8) 47.2 (19.6) 41.7 (17.1)
Follow-up: 2 months 36 32.9 (27.5) 83.9 (14.4) 77.0 (17.2)
Follow-up: 3 months 31 41.2 (26.1) 85.6 (15.2) 76.5 (15.3)
Follow-up: 4 months 31 51.8 (24.7) 84.2 (16.0) 80.6 (14.3)
Follow-up: 5 months 24 50.7 (27.7) 90.4 (10.8) 81.8 (14.1)
Follow-up: 12 months 40 68.6 (27.1) 92.3 (10.7) 84.2 (14.1)
Reference time point: 12 monthsb 37 59.3 (31.5) 89.2 (15.6) 79.4 (19.8)
Follow-up: 15 months 12 68.8 (24.6) 94.6 (8.4) 86.8 (9.2)
Follow-up: 18 months 16 59.0 (25.6) 88.8 (15.5) 78.2 (19.4)
Follow-up: 24 months 23 54.0 (31.0) 85.4 (19.2) 77.4 (19.6)
areference score for the 162 patients completing the transition item (change assessment) between 2 and 12 months after surgery
breference score for the 37 patients completing the transition item (change assessment) between 15 and 24months after surgery. In 14 patients change was
assessed at two different time points (i.e. 37 patients provided 51 assessments)
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Pain scale and of 7.2 points for the WOMAC Function
scale using a binary regression modelling approach.
These scores reflect the minimal score improvement
needed to represent a meaningful difference in patient
outcomes detectable using these tools. As only a very
low number of patients experienced a deterioration of
their joint health, we could not calculate MIDs for de-
terioration based on this sample. The correlations be-
tween the transition items and the change scores
indicate the validity of the change measurement.
In our study, we evaluated change across multiple dif-
ferent time points up to 2 years post-surgery to cover
different magnitudes of change, ranging from small to
large improvements. This approach differs from previous
studies [15, 21, 30] that determined MIDs based on data
collected within the first year after surgery that is in a
time span when patients mostly experience large
improvements.
We report MID values using the most recent predict-
ive modelling techniques as this is thought to offer more
Table 3 Descriptive statistics for the transition items for joint awareness (N = 213), pain (N = 205) and function (N = 206)
Fig. 1 FJS-12 score change for each category of the transition item for joint awareness (please note that no patient reported that joint awareness
was “much more”)
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accurate estimates than traditional ROC methodology
[14]. As is suggested by King [31], we also report values
from a different methodology, i.e. ROC analysis, which
also allows comparison to wider literature. As with pre-
vious studies [15, 21, 30] we demonstrate variation in
MID estimate with evaluation methodology.
The only previous estimate of MID for the FJS-12 in
literature is reported by Ingelsrud et al. [21] These au-
thors calculated a MID of 14.2 points for change in the
FJS-12 between pre-op and 1 year following TKA in a
Danish population using a predictive modelling ap-
proach. As we included patients up to 2 year after
Fig. 2 WOMAC Pain score change for each category of the transition item for pain (please note that no patient reported that pain was “much worse”)
Fig. 3 WOMAC Function score change for each category of the transition item for function (please note that no patient reported that function
was “much worse”)
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surgery and measured change not only in comparison to
pre-surgery but also against 1-year follow-up data, we
assume that the average improvement between the study
time point and the reference time point was substantially
smaller in our sample compared to the data presented
by Ingelsrud et al.. We hypothesize that this may impact
on the size of the MID, possibly as a result of patient ex-
pectations towards postoperative improvement, i.e. in
the early post-operative recovery phase, when patients
expect large improvements, smaller improvements may
not be perceived by the patient as such. Relying on data
only up to 1 year may than result in overestimation of
the MID for later follow-up time points.
The WOMAC is an older tool and has undergone
rigorous methodological evaluation over the years. As
such, a number of studies have reported MIDs for TKA
populations, therefore allowing for better comparison of
our study results and statistical methods. We are not
aware of any study that reports predictive modelling
MID estimates for the WOMAC osteoarthritis index,
however we can contrast our ROC analysis estimates.
Escobar et al. reported WOMAC Pain to be 22 points
(20.2–23.8 points) and WOMAC Function to be 24
points (22.7–24.7 points) using the ROC methodology.
These estimates are uncomfortably high as they exceed
the standard deviation of the baseline score. The review
by Devji et al. [32] provides an overview over further
MID estimates in non-surgical populations with values
ranging from 3.6 to 7.8 for pain and 4.7 to 17.1 for func-
tion. We would like to note that the lower estimates
might relate to a different WOMAC scoring, that is
resulting in a metric not ranging from 0 to 100. Terwee
et al. [16] reported values of 16.5 for pain and 9.6 for
function (rescaled to 0–100 for comparability to our
study). It is important to note that Terwee’s study in-
cluded a mixed population of hip and knee patients
undergoing joint arthroplasty.
Overall, the MIDs for improvement observed in our
study were somewhat smaller than those determined in
previous studies. A reason may be that we covered a lon-
ger follow-up period than most other studies on MIDs.
We argue that studies assessing change only in the first
year after surgery, when patients generally experience
large improvements may overestimate the MIDs, or
more specifically, may result in MIDs that are not valid
for later follow-up periods. The differences between
MIDs from ROC analysis and predictive modelling may
reflect that MID estimates from ROC analysis are less
precise [14]. While in the study by Ingelsrud et al. [21],
MIDs based on ROC analysis were as well larger than
MIDs from predictive modelling, this differences is sub-
stantially more pronounced in our analysis.
A limitation of our study was the size of our conveni-
ence sample that, while large enough for determining
overall MIDs, did not allow comparing statistically MIDs
for different follow-up periods, or specific patient
subgroups.
Conclusion
Our study has established MIDs for improvement for
the FJS-12 and the WOMAC Pain and Function scores
in a TKA patient cohort. In line with previous research,
we found more advanced statistical methods to result in
smaller MID estimates. Future research should investi-
gate if smaller changes are of clinical importance during
later follow-up periods compared to the early post-
operative recovery period.
Abbreviations
FJS-12: Forgotten Joint Score-12; MIDs: Minimal important differences;
OA: Osteoarthritis; PROMs: Patient-reported outcome measures;
ROC: Receiver operator characteristics; TKA: Total knee arthroplasty;




Holtz N was responsible for the study design including patient questionnaires,
data acquisition and has made substantial contributions to the conception and
writing the article. Hamilton DF was involved in evaluation and interpretation of
the data and writing the article. Giesinger JM was responsible for the study
design, statistical evaluation of the data and revision of the article. Jost B co-
designed, interpreted and revised the article. Giesinger KM designed the article
and was involved in interpretation, writing and revision of the article. The au-
thors read and approved the final manuscript.
Funding
This research did not receive any specific grant from funding agencies in the
public, commercial, or not-for-profit sectors.
Availability of data and materials
The anonymised datasets used and/or analysed during the current study are
available from the corresponding author on reasonable request.
Ethics approval and consent to participate
Ethical approval was granted by the local ethics committee
(Ethikkommission St. Gallen: EKSG 14/973).
Consent for publication
Written consent for this study was obtained from all participants.
Competing interests
Holtz N: The author declares that he has no competing interests.
Hamilton DF: The author declares that he gets research support from Stryker
company. He is on the editorial board of BMC Musculoskeletal Disorders.
Table 4 MIDs for the FJS-12, WOMAC Pain and WOMAC
Function scores
MID derived from logistic
regression analysis
MID derived from ROC
analysis








7.2 points 14.7 points (sensitivity 0.85,
specificity 0.76)
Holtz et al. BMC Musculoskeletal Disorders          (2020) 21:401 Page 7 of 9
Giesinger JM: The author declares that he is a copyright holder of the
Forgotten Joint Score-12. Royalties are payable for commercial use of the
questionnaire.
Jost B: The author declares that he is a payed consultant and gets royalities
from Medacta International. Furthermore, he gets financial support from
Johnson&Johnson. He works for the editorial board of the JBJSAm and is a
board member of Swiss orthopaedics.
Giesinger KM: The author declares that he is a copyright holder of the
Forgotten Joint Score-12. Royalties are payable for commercial use of the
questionnaire.
Author details
1Department of Orthopaedics and Traumatology, Kantonsspital St. Gallen,
Rorschacher Strasse 95, CH-9000 St. Gallen, Switzerland. 2Department of
Orthopaedics and Trauma, University of Edinburgh, Edinburgh, UK.
3Innsbruck Institute of Patient-Centered Outcome Research (IIPCOR),
Innsbruck, Austria. 4Department of Orthopaedics and Traumatology,
Kantonsspital St. Gallen, Rorschacher Strasse 95, CH-9000 St. Gallen,
Switzerland.
Received: 17 December 2019 Accepted: 9 June 2020
References
1. Clement ND, Macdonald D, Burnett R. Predicting patient satisfaction using
the Oxford knee score: where do we draw the line? Arch Orthop Trauma
Surg. 2013;133(5):689–94. https://doi.org/10.1007/s00402-013-1728-3.
2. Behrend H, Giesinger K, Giesinger JM, Kuster MS. The & quot; forgotten
joint&quot; as the ultimate goal in joint arthroplasty: validation of a new
patient-reported outcome measure. J Arthroplast. 2012;27(3):430–436.e1.
https://doi.org/10.1016/j.arth.2011.06.035.
3. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study
of WOMAC: a health status instrument for measuring clinically important
patient relevant outcomes to antirheumatic drug therapy in patients with
osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40 http://
www.ncbi.nlm.nih.gov/pubmed/3068365. Accessed July 7, 2018.
4. Paradowski PT, Roos EM. Knee outcome scales: basic concepts, review of
methods, cross-cultural and linguistic adaptation. Ortop Traumatol Rehabil.
2004;6(4):393–405 http://www.ncbi.nlm.nih.gov/pubmed/17675966.
Accessed July 7, 2018.
5. Collins NJ, Roos EM. Patient-reported outcomes for total hip and knee
arthroplasty: commonly used instruments and attributes of a & quot; good
& quot; measure. Clin Geriatr Med. 2012;28(3):367–94. https://doi.org/10.
1016/j.cger.2012.05.007.
6. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the knee society clinical
rating system. Clin Orthop Relat Res. 1989;248:13–4 http://www.ncbi.nlm.nih.
gov/pubmed/2805470. Accessed July 7, 2018.
7. Roos EM, Roos HP, Ekdahl C, Lohmander LS. Knee injury and osteoarthritis
outcome score (KOOS)--validation of a Swedish version. Scand J Med Sci
Sports. 1998;8(6):439–48 http://www.ncbi.nlm.nih.gov/pubmed/9863983.
Accessed July 7, 2018.
8. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey:
construction of scales and preliminary tests of reliability and validity. Med
Care. 1996;34(3):220–33 http://www.ncbi.nlm.nih.gov/pubmed/8628042.
Accessed July 7, 2018.
9. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36).
I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83
http://www.ncbi.nlm.nih.gov/pubmed/1593914. Accessed July 7, 2018.
10. Dawson J, Fitzpatrick R, Murray D, Carr A. Questionnaire on the perceptions
of patients about total knee replacement. J Bone Joint Surg (Br). 1998;80(1):
63–9 http://www.ncbi.nlm.nih.gov/pubmed/9460955. Accessed July 7, 2018.
11. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining
the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–
15 http://www.ncbi.nlm.nih.gov/pubmed/2691207. Accessed January 2, 2019.
12. King MT, Dueck AC, Revicki DA. Can methods developed for interpreting
group-level patient-reported outcome data be applied to individual patient
management? Med Care. 2019;57(Suppl 5 Suppl 1):S38–45. https://doi.org/
10.1097/MLR.0000000000001111.
13. McGlothlin AE, Lewis RJ. Minimal clinically important difference: defining
what really matters to patients. JAMA. 2014;312(13):1342–3. https://doi.org/
10.1001/jama.2014.13128.
14. Terluin B, Eekhout I, Terwee CB, de Vet HCW. Minimal important change
(MIC) based on a predictive modeling approach was more precise than MIC
based on ROC analysis. J Clin Epidemiol. 2015;68(12):1388–96. https://doi.
org/10.1016/j.jclinepi.2015.03.015.
15. Escobar A, García Pérez L, Herrera-Espiñeira C, et al. Total knee replacement;
minimal clinically important differences and responders. Osteoarthr Cartil.
2013;21(12):2006–12. https://doi.org/10.1016/j.joca.2013.09.009.
16. Terwee CB, Roorda LD, Knol DL, De Boer MR, De Vet HCW. Linking
measurement error to minimal important change of patient-reported
outcomes. J Clin Epidemiol. 2009;62(10):1062–7. https://doi.org/10.1016/J.
JCLINEPI.2008.10.011.
17. Giesinger K, Hamilton DF, Jost B, Holzner B, Giesinger JM. Comparative
responsiveness of outcome measures for total knee arthroplasty. Osteoarthr
Cartil. 2014;22(2):184–9. https://doi.org/10.1016/j.joca.2013.11.001.
18. Wheatley B, Nappo K, Fisch J, Rego L, Shay M, Cannova C. Early outcomes
of patient-specific posterior stabilized total knee arthroplasty implants. J
Orthop. 2019;16(1):14–8. https://doi.org/10.1016/j.jor.2018.11.003.
19. Giesinger JM, Behrend H, Hamilton DF, Kuster MS, Giesinger K. Normative
values for the forgotten joint Score-12 for the US general population. J
Arthroplast. 2018;34(4):650. https://doi.org/10.1016/j.arth.2018.12.011.
20. Edelstein A, Bhatt S, Wright-Chisem J, Sullivan R, Beal M, Manning D. The
effect of implant design on sagittal plane stability: a randomized trial of
medial- versus posterior-stabilized Total knee arthroplasty. J Knee Surg.
2019;33(05):452. https://doi.org/10.1055/s-0039-1678524.
21. Ingelsrud LH, Roos EM, Terluin B, Gromov K, Husted H, Troelsen A. Minimal
important change values for the Oxford knee score and the forgotten joint
score at 1 year after total knee replacement. Acta Orthop. 2018;89(5):541–7.
https://doi.org/10.1080/17453674.2018.1480739.
22. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for
determining responsiveness and minimally important differences for
patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–9. https://doi.
org/10.1016/j.jclinepi.2007.03.012.
23. Thienpont E, Opsomer G, et al. AK-TJ of, 2014 undefined. Joint awareness in
different types of knee arthroplasty evaluated with the forgotten joint score:
Elsevier. https://www.sciencedirect.com/science/article/pii/S08835403130032
88. Accessed July 7, 2018.
24. Hamilton DF, Loth FL, Giesinger JM, et al. Validation of the English language
forgotten joint Score-12 as an outcome measure for total hip and knee
arthroplasty in a British population. Bone Joint J. 2017;99-B(2):218–24.
https://doi.org/10.1302/0301-620X.99B2.BJJ-2016-0606.R1.
25. Matsumoto M, Baba T, Homma Y, et al. Validation study of the forgotten
joint Score-12 as a universal patient-reported outcome measure. Eur J
Orthop Surg Traumatol. 2015;25(7):1141–5. https://doi.org/10.1007/s00590-
015-1660-z.
26. Baumann F, Ernstberger T, Loibl M, Zeman F, Nerlich M, Tibesku C.
Validation of the German forgotten joint score (G-FJS) according to the
COSMIN checklist: does a reduction in joint awareness indicate clinical
improvement after arthroplasty of the knee? Arch Orthop Trauma Surg.
2016;136(2):257–64. https://doi.org/10.1007/s00402-015-2372-x.
27. Hamilton DF, Giesinger JM, MacDonald DJ, Simpson AHRW, Howie CR,
Giesinger K. Responsiveness and ceiling effects of the forgotten joint Score-
12 following total hip arthroplasty. Bone Joint Res. 2016;5(3):87–91. https://
doi.org/10.1302/2046-3758.53.2000480.
28. Thomsen MG, Latifi R, Kallemose T, Barfod KW, Husted H, Troelsen A. Good
validity and reliability of the forgotten joint score in evaluating the outcome
of total knee arthroplasty. Acta Orthop. 2016;87(3):280–5. https://doi.org/10.
3109/17453674.2016.1156934.
29. Shadid MB, Vinken NS, Marting LN, Wolterbeek N. The Dutch version of the
forgotten joint score: test-retesting reliability and validation. Acta Orthop
Belg. 2016;82(1):112–8 http://www.ncbi.nlm.nih.gov/pubmed/26984663.
Accessed September 24, 2019.
30. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically
important differences of rehabilitation intervention with their implications
for required sample sizes using WOMAC and SF-36 quality of life
measurement instruments in patients with osteoarthritis of the lower
extremities. Arthritis Rheum. 2001;45(4):384–91. https://doi.org/10.1002/
1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0.
31. King MT. A point of minimal important difference (MID): a critique of
terminology and methods. Expert Rev Pharmacoecon Outcomes Res. 2011;
11(2):171–84. https://doi.org/10.1586/erp.11.9.
Holtz et al. BMC Musculoskeletal Disorders          (2020) 21:401 Page 8 of 9
32. Devji T, Guyatt GH, Lytvyn L, et al. Application of minimal important
differences in degenerative knee disease outcomes: a systematic review and
case study to inform BMJ rapid recommendations. BMJ Open. 2017;7(5):
e015587. https://doi.org/10.1136/bmjopen-2016-015587.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Holtz et al. BMC Musculoskeletal Disorders          (2020) 21:401 Page 9 of 9
